Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maraviroc in acute HIV infection
2008-007004-29Phase 2Completed
- Sponsor
- IRCCS Ospedale San Raffaele
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of maraviroc in human immunodeficiency virus infection (HIV) and Seroconversion Syndrome (2 arms), sponsored by IRCCS Ospedale San Raffaele. Primary endpoint: Mean change from baseline in CD4 count at Week 48. Started Mar 2009; status: completed.
02
Drugs
maraviroc
03
Conditions
human immunodeficiency virus infection (HIV)Seroconversion Syndrome
Beyond the preview
Go deeper on 2008-007004-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007004-29.